New diabetes clinical trial: Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes
Published on: January 19, 2023 at 11:00AM
Condition: Type 1 Diabetes
Intervention: Drug: HDV-Insulin Lispro
Sponsors: University of California, San Diego; The Leona M. and Harry B. Helmsley Charitable Trust
Not yet recruiting
https://ift.tt/azBIupX
Condition: Type 1 Diabetes
Intervention: Drug: HDV-Insulin Lispro
Sponsors: University of California, San Diego; The Leona M. and Harry B. Helmsley Charitable Trust
Not yet recruiting
https://ift.tt/azBIupX
Comments
Post a Comment